ERBB2 and breast cancer: The Surveillance, Epidemiology, and End Results Program conducted a study on the association between breast cancer subtypes and distant metastatic sites [26] There is a strong correlation between bone metastasis risk and the HR+/HER2+ (luminalHER2) subtypes, according to these findings.